APR에이피알
278470 · KOSPI · ₩278470 · 에이피알
Analyst target price
Average target
₩535,000
Upside
+92.4%
Range ₩520,000 – ₩550,000 · 2 brokers (latest target within 6 months)
Buy 1
Consensus target vs price, 2 years
Broker reports
| Date | Broker | Report | Rating | Target | Change | Upside | Since publish | Read |
|---|---|---|---|---|---|---|---|---|
| Oct 13 | Kyobo Securities | FX is a burden, but expectations for 4Q main season | — | — | — | −1.8% | Read ↗ | |
| Oct 13 | Kyobo Securities | FX is a burden, but expectations for 4Q main season | Buy | ₩550,000 | Maintained | +97.8% | −1.8% | Read ↗ |
| Oct 13 | Kyobo Securities | FX is a burden, but expectations for 4Q main season | Buy | ₩550,000 | Maintained | +97.8% | −1.8% | Read ↗ |
All 7 broker reports on APR, not just the latest 3, with Pro.
Unlock with ProCalculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
Reported in the news
| Date | Broker | Target | Change | Rating | Source |
|---|---|---|---|---|---|
| Oct 21 | — | ₩550,000 | — | Reported by The Financial News | |
| Oct 14 | Korea Investment & Securities | ₩520,000 | Maintained | — | Reported by Chosun Biz |
| Oct 13 | — | — | Cut | — | Reported by The Financial News |
| Oct 13 | — | — | Cut | — | Reported by Edaily |
| Oct 12 | SK Securities | — | Cut | — | Reported by Yonhap News Agency |
Target prices and ratings as news headlines report them, for every broker, including the ones whose reports we don't collect. Only what the headline says; open the article for the rest. Not financial advice.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
APR's profits have grown fast, but the shares are down sharply over the past month after an exchange plan to designate the company as unfaithful in disclosure.
APR is a Korean beauty company with fast revenue growth, reaching ₩2.29T in trailing twelve-month revenue to H1 2026 with an 18.2% operating margin. The share price closed at ₩282,000 on 26 October 2026, down 23.5% over one month but up 18.2% over one year. The exchange has announced a plan to designate the company as an unfaithful disclosure entity following a leak of earnings information, and a full probe is under way.
What stands out
- Revenue rose 111.3% in 2025 to ₩1.53T, and trailing revenue to H1 2026 is ₩2.29T, showing strong growth.
- Trailing operating income is ₩417B and net income is ₩432B, with an 18.8% net margin and ROE of 89%.
- Valuation is high against the data given: P/E 24.4, P/B 16.3, EV/EBITDA 24.1, versus Amorepacific at P/E 25.7 and most other peers at P/E 15 to 17.
- The discounted cash flow model gives a base value of ₩189,651 with a bear case of ₩125,988 and a bull case of ₩289,381, so the current price sits above the base case.
- Overseas sales are about 80% of revenue, and recent headlines report Medicube entering Costco's roughly 400 US stores after Walmart, Ulta and Target.
What to watch
- Whether the exchange's unfaithful-disclosure designation and leak probe proceed, and what they mean for the company and its shares.
- The status of the merger decision disclosed in September 2026, including any amended terms.
- Next earnings results, which are not in the data; the advance notice in October gave no figures beyond what is listed.
- Currency pressure, which one headline cites as a factor against demand, and the short balance of 2.8% alongside recent foreign buying.
Data as of Oct 26, 2026 · written yesterday
This is not financial advice.
Also known as: APR / 에이피알 / 278470 / KRX:278470
Source: KRX statistical information